These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20372988)

  • 1. Microneedles with intrinsic immunoadjuvant properties: microfabrication, protein stability, and modulated release.
    Andrianov AK; Marin A; DeCollibus DP
    Pharm Res; 2011 Jan; 28(1):58-65. PubMed ID: 20372988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal immunization using coated microneedles containing an immunoadjuvant.
    Andrianov AK; Mutwiri G
    Vaccine; 2012 Jun; 30(29):4355-60. PubMed ID: 22682291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.
    Andrianov AK; DeCollibus DP; Gillis HA; Kha HH; Marin A; Prausnitz MR; Babiuk LA; Townsend H; Mutwiri G
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18936-41. PubMed ID: 19864632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coating formulations for microneedles.
    Gill HS; Prausnitz MR
    Pharm Res; 2007 Jul; 24(7):1369-80. PubMed ID: 17385011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.
    Andrianov AK; Marin A; Roberts BE
    Biomacromolecules; 2005; 6(3):1375-9. PubMed ID: 15877355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.
    Payne LG; Jenkins SA; Woods AL; Grund EM; Geribo WE; Loebelenz JR; Andrianov AK; Roberts BE
    Vaccine; 1998 Jan; 16(1):92-8. PubMed ID: 9607015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-Functionalized Polyphosphazene Immunoadjuvant: Synthesis, Solution Behavior and In Vivo Potency.
    Tagad HD; Marin A; Wang R; Yunus AS; Fuerst TR; Andrianov AK
    Molecules; 2023 May; 28(10):. PubMed ID: 37241958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCPP-formulated H5N1 influenza vaccine displays improved stability and dose-sparing effect in lethal challenge studies.
    Andrianov AK; Decollibus DP; Marin A; Webb A; Griffin Y; Webby RJ
    J Pharm Sci; 2011 Apr; 100(4):1436-43. PubMed ID: 20960569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer microneedles for controlled-release drug delivery.
    Park JH; Allen MG; Prausnitz MR
    Pharm Res; 2006 May; 23(5):1008-19. PubMed ID: 16715391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery.
    Payne LG; Jenkins SA; Andrianov A; Roberts BE
    Pharm Biotechnol; 1995; 6():473-93. PubMed ID: 7551232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein stabilization in aqueous solutions of polyphosphazene polyelectrolyte and non-ionic surfactants.
    Marin A; Decollibus DP; Andrianov AK
    Biomacromolecules; 2010 Sep; 11(9):2268-73. PubMed ID: 20681734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulatory effect of tetanus toxoid loaded chitosan nanoparticles following microneedles assisted immunization.
    Siddhapura K; Harde H; Jain S
    Nanomedicine; 2016 Jan; 12(1):213-22. PubMed ID: 26554391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein encapsulation in polymeric microneedles by photolithography.
    Kochhar JS; Zou S; Chan SY; Kang L
    Int J Nanomedicine; 2012; 7():3143-54. PubMed ID: 22787403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.
    Marin A; Chowdhury A; Valencia SM; Zacharia A; Kirnbauer R; Roden RBS; Pinto LA; Shoemaker RH; Marshall JD; Andrianov AK
    Nanomedicine; 2021 Apr; 33():102359. PubMed ID: 33476764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembly of polyphosphazene immunoadjuvant with poly(ethylene oxide) enables advanced nanoscale delivery modalities and regulated pH-dependent cellular membrane activity.
    Andrianov AK; Marin A; Fuerst TR
    Heliyon; 2016 Apr; 2(4):e00102. PubMed ID: 27441274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coated microneedles for transdermal delivery.
    Gill HS; Prausnitz MR
    J Control Release; 2007 Feb; 117(2):227-37. PubMed ID: 17169459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin immunization with third-generation hepatitis B surface antigen using microneedles.
    Nguyen TT; Choi JA; Kim JS; Park H; Yang E; Lee WJ; Baek SK; Song M; Park JH
    Vaccine; 2019 Sep; 37(40):5954-5961. PubMed ID: 31466705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on coating/manufacturing techniques of microneedles.
    Tarbox TN; Watts AB; Cui Z; Williams RO
    Drug Deliv Transl Res; 2018 Dec; 8(6):1828-1843. PubMed ID: 29288358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action.
    Magiri R; Mutwiri G; Wilson HL
    Cell Tissue Res; 2018 Dec; 374(3):465-471. PubMed ID: 30294754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery.
    Park JH; Allen MG; Prausnitz MR
    J Control Release; 2005 May; 104(1):51-66. PubMed ID: 15866334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.